The IGF system in neuroblastoma xenografts: Focus on IGF-binding protein-6

Journal of Endocrinology

Volumn 172, Issue 3, 2002, Pages 467-476

  Grellier, P ^a   Berrebi, D ^a   Peuchmaur, M ^a   Babajko, S ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; MESSENGER RNA; PLASMINOGEN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C RECEPTOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CORRELATION FUNCTION; CULTURE MEDIUM; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MITOGENESIS; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NICK END LABELING; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STAINING; XENOGRAFT;

ANIMALS; APOPTOSIS; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SOMATOMEDINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036125934     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1720467     Document Type: Article

References (40)

1. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells
2. IGF-I binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells: Its production is both IGF- and cell density-dependent
3. Signalling pathways involved in antiproliferative effects of IGFBP-3: A review
4. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily
5. Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium of neuroblastoma cells
6. Overexpression of insulin-like growth factor binding protein-2 in C6 glioma cells result in conditional alteration of cellular growth
7. The IGF axis and programmed cell death
8. N-myc regulation of type 1 insulin-like growth factor receptor in a human neuroblastoma cell line
9. A second signal supplied by insulin-like growth factor-II in oncogene-induced tumorigenesis
10. Do insulin-like growth factor binding proteins (IGFBP) modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells?
11. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4 delays onset of prostate tumor formation
12. The insulin-like growth factor-I receptor: Structure, ligand binding mechanism and signal transduction
13. Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid
14. Insulin-like growth factor-II-mediated proliferation of human neuroblastoma
15. IGF binding protein-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation
16. Co-activation of the MDR-1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse
17. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells
18. Elevated serum insulin-like growth factor binding protein-2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor
19. Reactivation of insulin-like growth factor binding protein-2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling
20. Expression of insulin-like growth factor (IGF) binding protein-6 complementary DNA alters neuroblastoma cell growth
21. Over-expression of insulin-like growth factor binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells
22. Insulin-like growth factors and their binding proteins: Biological actions
23. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factors and insulin-like growth factor binding protein-6, in a calcium and cell density-dependent manner
24. Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II but not basal proliferation and adhesion of LIM 1215 colon cancer cells
25. Molecular and cellular aspects of the insulin-like growth factor-I receptor
26. Extraction, purification and analysis of mRNA from eukaryotic cells
27. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: Modulation by transforming growth factor-beta and retinoic acid
28. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity
29. N-myc induction stimulated by insulin-like growth factor-I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells
30. Insulin-like growth factor binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia
31. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
32. Insulin-like growth factor binding protein gene expression and protein production by human tumor cell lines
33. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice
34. Insulin-like growth factor (IGF-I) and the IGF-I receptor prevent etoposid-induced apoptosis
35. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, -6)
36. Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors
37. Insulin-like growth factor-II in the pathogenesis of human neuroblastoma
38. An IGF binding protein is an inhibitor of FGF stimulation
39. The role of the insulin-like growth factor system in human cancer
40. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: Potential diagnostic and therapeutic perspectives